Evidence map›Paper›PMID 34173032›Full record

ArticlePsychopharmacology2021

Evidence accumulation and associated error-related brain activity as computationally-informed prospective predictors of substance use in emerging adulthood.

Alexander S Weigard, Sarah J Brislin, Lora M Cope, Jillian E Hardee, Meghan E Martz, Alexander Ly, Robert A Zucker, Chandra Sripada, Mary M Heitzeg

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Model-based analysis of stop-signal data reveals robust neural and clinical correlates of evidence accumulation but not inhibition.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Candidate biomarkers in psychiatric disorders: state of the field.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Alexander S WeigardDepartment of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109, USA. asweigar@med.umich.edu.
Sarah J BrislinDepartment of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109, USA.
Lora M CopeDepartment of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109, USA.
Jillian E HardeeDepartment of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109, USA.
Meghan E MartzDepartment of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109, USA.
Alexander LyDepartment of Psychological Methods, University of Amsterdam, Amsterdam, The Netherlands.
Robert A ZuckerDepartment of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109, USA.
Chandra SripadaDepartment of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109, USA.
Mary M HeitzegDepartment of Psychiatry, University of Michigan, Rachel Upjohn Building, 4250 Plymouth Road, Ann Arbor, MI, 48109, USA.
University of Michigan–Ann Arbor · USUniversity of Amsterdam · NL

Funding

MULTIDISCIPLINARY ALCOHOLISM RESEARCH TRAINING PROGRAMT32AA007477 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maureen A. Walton · 1990 to 2026
$7.4M
RISK AND COPING IN CHILDREN OF ALCOHOLICSR01AA007065 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HEITZEG, MARY M · 1987 to 2017
$6.1M
Developmental neurobiological and contextual influences on alcohol use disorderR01AA025790 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HEITZEG, MARY M, HICKS, BRIAN M · 2018 to 2022
$2.8M
Impulsivity as Immaturity: Mapping Dysmaturation of the Brain's Control Architecture in Youth Externalizing PsychopathologyR01MH107741 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SRIPADA, CHANDRA SEKHAR · 2015 to 2019
$2.3M
Multi-method signature of risk for compulsive substance use: Human translation of the incentive-sensitization modelK01DA044270 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COPE, LORA M. · 2019 to 2023
$835k
Sex differences in the neural mechanisms of brief interventions for binge drinkingK01AA024804 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HARDEE, JILLIAN ELIZABETH · 2016 to 2020
$830k
Developmental and sex differences in modulation of nucleus accumbens activationK01AA027558 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARTZ, MEGHAN ELIZABETH · 2019 to 2023
$826k
NIAAA NIH HHS K01 AA024804NIAAA NIH HHS K01 AA027558NIAAA NIH HHS R01 AA007065NIAAA NIH HHS R01 AA025790NIAAA NIH HHS T32 AA007477NIDA NIH HHS K01 DA044270NIMH NIH HHS R01 MH107741
6 · The paper itself

Abstract

rationaleSubstance use peaks during the developmental period known as emerging adulthood (ages 18-25), but not every individual who uses substances during this period engages in frequent or problematic use. Although individual differences in neurocognition appear to predict use severity, mechanistic neurocognitive risk factors with clear links to both behavior and neural circuitry have yet to be identified. Here, we aim to do so with an approach rooted in computational psychiatry, an emerging field in which formal models are used to identify candidate biobehavioral dimensions that confer risk for psychopathology.

objectivesWe test whether lower efficiency of evidence accumulation (EEA), a computationally characterized individual difference variable that drives performance on the go/no-go and other neurocognitive tasks, is a risk factor for substance use in emerging adults. METHODS AND

resultsIn an fMRI substudy within a sociobehavioral longitudinal study (n = 106), we find that lower EEA and reductions in a robust neural-level correlate of EEA (error-related activations in salience network structures) measured at ages 18-21 are both prospectively related to greater substance use during ages 22-26, even after adjusting for other well-known risk factors. Results from Bayesian model comparisons corroborated inferences from conventional hypothesis testing and provided evidence that both EEA and its neuroimaging correlates contain unique predictive information about substance use involvement.

conclusionsThese findings highlight EEA as a computationally characterized neurocognitive risk factor for substance use during a critical developmental period, with clear links to both neuroimaging measures and well-established formal theories of brain function.

Indexed as

Substance-Related DisordersAdolescentAdultBayes TheoremBrainFemaleHumansLongitudinal StudiesMalePsychopathologyYoung AdultComputational psychiatryDiffusion modelDrift rateEvidence accumulationSalience networkSubstance use

Identifiers

PMID34173032
PMCPMC8452274
OpenAlexW3174653426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.